Search

everythinglearnresearchcommunity

for

Search:↓

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Different genes are linked to various types of hair loss.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

The exact causes of baldness are not fully understood, limiting treatment options.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Serenoa repens and N-acetyl glucosamine/milk proteins complex may help with hair growth and prevent hair loss.

β-sitosterol and brassicasterol may help treat hair loss.

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.